Determination of valsartan drug by ion pair complex formation method in tablet form
DOI:
https://doi.org/10.69923/851hfy94Keywords:
Ion pair ,Pharmaceutical ,Spectrophotometer, Tablets, ValsartanAbstract
A rapid, simple, sensitive, spectroscopic, ion pair complex method was developed for valsartan (VAL ) in pharmaceutical forms. Resazurin dye was used to form an ion pairing complex with the drug valsartan. analytical characteristics of the proposed method are Beer’s law range =10-60 (μg/mL), correlation coefficient (R2) = 0.9976 , limit of detection (LOD) = 0.1076(µg/mL), limit of quantification (LOQ) = 0.3261 (µg/mL), recovery percentage (%Rec) = (101.9626% - 95.6074%), relative standard deviation (%RSD)= 0.6188% - 0.7148%, Molar absorption (ε)= 4659.85(L/mol.cm), Sandell's index(S) = 0.093458(μg/cm2),at wavelength 495 nm . The results showed high accuracy and precision of the proposed quantification method for the valsartan drug , and it was of high accuracy and consistent.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Iraqi Journal for Applied Sciences

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licenses and Copyright
The copyright of this article is retained by the author(s).
This article is published by the Iraqi Journal for Applied Science (IJAS) under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
This license permits unrestricted use, distribution, reproduction, adaptation, and reuse of the work in any medium or format, including commercial use, provided that appropriate credit is given to the original author(s) and the source, a link to the license is provided, and any modifications are indicated.
Authors retain full copyright of their work and grant IJAS a non-exclusive license to publish, archive, preserve, and disseminate the article, including registration of metadata and Digital Object Identifiers (DOIs) through Crossref.
Any third-party material included in this article remains subject to its respective copyright and licensing conditions. Authors are responsible for obtaining all necessary permissions for such material before publication.
For complete details regarding copyright, licensing, permissions, and reuse, please refer to the journal's Copyright and Licensing Policy available on the IJAS website.
License: https://creativecommons.org/licenses/by/4.0/



